These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21537513)

  • 1. Design and synthesis of pyrrolidine-containing sphingomimetics.
    Lee S; Lee S; Park HJ; Lee SK; Kim S
    Org Biomol Chem; 2011 Jun; 9(12):4580-6. PubMed ID: 21537513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereoselective synthesis of constrained azacyclic hydroxyethylene isosteres as aspartic protease inhibitors: dipolar cycloaddition and related methodologies toward branched pyrrolidine and pyrrolidinone carboxylic acids.
    Hanessian S; Yun H; Hou Y; Tintelnot-Blomley M
    J Org Chem; 2005 Aug; 70(17):6746-56. PubMed ID: 16095294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of piperidine-containing sphingoid base analogues.
    Cho J; Lee YM; Kim D; Kim S
    J Org Chem; 2009 May; 74(10):3900-4. PubMed ID: 19358583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diversity oriented and chemoenzymatic synthesis of densely functionalized pyrrolidines through a highly diastereoselective Ugi multicomponent reaction.
    Cerulli V; Banfi L; Basso A; Rocca V; Riva R
    Org Biomol Chem; 2012 Feb; 10(6):1255-74. PubMed ID: 22215069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enantioselective biotransformations of racemic and meso pyrrolidine-2,5-dicarboxamides and their application in organic synthesis.
    Chen P; Gao M; Wang DX; Zhao L; Wang MX
    J Org Chem; 2012 Apr; 77(8):4063-72. PubMed ID: 22463383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of 3-arylpyrrolidine-2-carboxamide derivatives as melanocortin-4 receptor ligands.
    Tran JA; Tucci FC; Arellano M; Jiang W; Chen CW; Marinkovic D; Fleck BA; Wen J; Foster AC; Chen C
    Bioorg Med Chem Lett; 2008 Mar; 18(6):1931-8. PubMed ID: 18294847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of a 2-aryl polyhydroxylated pyrrolidine alkaloid-based library.
    Tsou EL; Chen SY; Yang MH; Wang SC; Cheng TR; Cheng WC
    Bioorg Med Chem; 2008 Dec; 16(24):10198-204. PubMed ID: 19008111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-O tethered carbenoid cyclopropanation facilitates the synthesis of a functionalized cyclopropyl-fused pyrrolidine.
    Kalia D; Merey G; Guo M; Sintim HO
    J Org Chem; 2013 Jun; 78(12):6131-42. PubMed ID: 23701258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementary stereocontrolled approaches to 2-pyrrolidinones bearing a vicinal amino diol subunit with three continuous chiral centers: a formal asymmetric synthesis of (-)-detoxinine.
    Zhou X; Liu WJ; Ye JL; Huang PQ
    J Org Chem; 2007 Nov; 72(23):8904-9. PubMed ID: 17949109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lewis acid-promoted cyclization reactions of alkenyl ethenetricarboxylates: stereoselective synthesis of 2-oxotetrahydrofurans and 2-oxopyrrolidines.
    Yamazaki S; Fujinami K; Maitoko Y; Ueda K; Kakiuchi K
    J Org Chem; 2013 Sep; 78(17):8405-16. PubMed ID: 23885757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-Branched pyrrolidines from 2-C-acetylmethyl-glycosylazides. Reduction of imines formed by monosaccharide ring opening.
    Shao H; Williams DT; Wu SH; Zou W
    Carbohydr Res; 2006 Oct; 341(14):2434-8. PubMed ID: 16879813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FeCl3 promoted highly regioselective [3 + 2] cycloaddition of dimethyl 2-vinyl and aryl cyclopropane-1,1-dicarboxylates with aryl isothiocyanates.
    Wang H; Yang W; Liu H; Wang W; Li H
    Org Biomol Chem; 2012 Jul; 10(26):5032-5. PubMed ID: 22647999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of 2,2-disubstituted pyrrolidine-4-carboxylic acid derivatives and their incorporation into beta-peptide oligomers.
    Huck BR; Gellman SH
    J Org Chem; 2005 Apr; 70(9):3353-62. PubMed ID: 15844969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catalyst-controlled ring-opening cycloisomerization reactions of cyclopropenyl carboxylates for highly regioselective synthesis of different 2-alkoxyfurans.
    Chen J; Ma S
    Chem Asian J; 2010 Nov; 5(11):2415-21. PubMed ID: 20806315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico design and synthesis of piperazine-1-pyrrolidine-2,5-dione scaffold-based novel malic enzyme inhibitors.
    Zhang YJ; Wang Z; Sprous D; Nabioullin R
    Bioorg Med Chem Lett; 2006 Feb; 16(3):525-8. PubMed ID: 16288866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syntheses and biological evaluation of new fluoroquinolone antibacterials containing chiral oxiimino pyrrolidine.
    Choi DR; Shin JH; Yang J; Yoon SH; Jung YH
    Bioorg Med Chem Lett; 2004 Mar; 14(5):1273-7. PubMed ID: 14980680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of cytotoxic aza analogues of jaspine B.
    Rives A; Ladeira S; Levade T; Andrieu-Abadie N; Génisson Y
    J Org Chem; 2010 Nov; 75(22):7920-3. PubMed ID: 20954692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.
    Cheng XC; Wang Q; Fang H; Tang W; Xu WF
    Eur J Med Chem; 2008 Oct; 43(10):2130-9. PubMed ID: 18362041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleophilic ring-opening of epoxide and aziridine acetates for the stereodivergent synthesis of β-hydroxy and β-amino γ-lactams.
    Bisol TB; Bortoluzzi AJ; Sá MM
    J Org Chem; 2011 Feb; 76(3):948-62. PubMed ID: 21194209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of enantiopure pyrrolidine-derived peptidomimetics and oligo-beta-peptides via nucleophilic ring-opening of beta-lactams.
    Macías A; Ramallal AM; Alonso E; del Pozo C; González J
    J Org Chem; 2006 Sep; 71(20):7721-30. PubMed ID: 16995679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.